Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Aselsan, Turkey's leading defense company, is increasing its focus on medical technology to support localization of medical devices. The company has started projects to develop and produce mobile X-ray and MRI systems, as well as defibrillators.
Latest From Innovation
Starts & Stops: MedAutonomic Initiates Phoenix Neuromodulation Stomach Implant Trial; Boston Scientific Completes S-ICD Trial Enrollment
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 17 through Sept. 23, including trial announcements from Boston Scientific, MedAutonomic, Desiral, and Edwards Lifesciences.
Data presented at the Transcatheter Cardiovascular Therapeutics conference Sept. 23 in San Diego will support expanding the label of Abbott's MitraClip mitral valve repair device to include secondary, or functional, mitral regurgitation, a company executive tells Medtech Insight. In the COAPT trial, MitraClip reduced the two-year rate of heart-failure hospitalization and all-cause mortality in patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation.
Results Recap: Terumo PulseCath Shows Promise In High-Risk PCI; Reapplix' LeucoPatch Promotes Ulcer-Healing
Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition covers the week of Sept. 14-20, including trial announcements from Nanobiotix, Reapplix, Profound Medical, Sequana Medical, and Terumo.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. Tech giant Apple led this round's news with two US FDA approvals for heart-rhythm-analysis apps embedded in the new Apple Watch.
Results Recap is a new regular feature in Medtech Insight providing a summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition includes trial announcements from NeuroMetrix, Vertos, LivaNova, and Boston Scientific.
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 3 through Sept. 9, including trial announcements from Nexstim PLC, PathMaker Neurosystems, Proven Process Medical Devices, and Edwards Lifesciences.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. This week, five approvals were added from Europe, Israel and Japan.
UK Innovation, EU Regulation And Digital Transformation Are Top Themes For Medtechs At NHS Expo 2018
NHS England chief Simon Stevens has a habit of stealing headlines in UK health-care circles, and his CAR-T cell therapy approval announcement did the trick at the NHS 2018 Innovation Expo. But medtech innovation schemes and furthering the UK digital agenda emerged as main talking points at the meeting.
Innovation keeps device-makers growing, and even for established behemoths like Johnson & Johnson, cultivating a healthy innovative pipeline is critical to ensuring that they stay on top. J&J's Mirren Mandalia explains what he looks for when scouting for new technologies.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.